Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III, Multicenter, Open-label, Randomized Clinical Trial to Evaluate Efficacy of Sodium Zirconium Cyclosilicate (Lokelma) Compared to Standard of Care to Manage Hyperkalemia in Patients With Chronic Kidney Disease (CKD)

NCT06578533 is registered in ClinicalTrials.gov with Fundación para la Investigación del Hospital Clínico de Valencia as lead sponsor.

NCT NCT06578533
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06578533 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III, Multicenter, Open-label, Randomized Clinical Trial to Evaluate Efficacy of Sodium Zirconium Cyclosilicate (Lokelma) Compared to Standard of Care to Manage Hyperkalemia in Patients With Chronic Kidney Disease (CKD)
Lead sponsor
Fundación para la Investigación del Hospital Clínico de Valencia
Phase
Phase 3
Overall status
Recruiting
Start date
September 30, 2022
Completion date
July 30, 2027
Enrollment
78 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney diseases